Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
SPRY
ARS Pharmaceuticals Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
ARS Pharmaceuticals Inc (SPRY) Earnings
Last reported
May 15, 2026
EPS estimate
-$0.51
EPS actual
—
Revenue est.
$22.8M
Revenue actual
—
Related:
SPRY overview
·
SPRY financials
·
SPRY news